MIB-1 index in thyroid tumors: A predictor of the clinical course in papillary thyroid carcinoma?

Thyroid

Volumn 13, Issue 4, 2003, Pages 371-380

  Kjellman, Petra ^a   Wallin, Göran ^a   Höög, Anders ^a   Auer, Gert ^a   Larsson, Catharina ^a   Zedenius, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; TUMOR MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

EID: 0038363775     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503321669866     Document Type: Article

References (27)

1. Hedinger C, Williams E, Sobin L 1988 Histological Typing of Thyroid Tumors. The WHO International Histological Classification of Thyroid Tumors, 2nd rev. ed. Springer-Verlag, Berlin.
2. Mazzaferri EL, Kloos RT 2001 Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447-1463.
3. Nilsson O, Lindeberg J, Zedenius J, Ekman E, Tennvall J, Blomgren H, Grimelius L, Lundell G, Wallin G 1998 Anaplastic giant cell carcinoma of the thyroid gland: Treatment and survival over a 25-year period. World J Surg 22:725-730.
4. American Joint Committee on Cancer 1992 Head and neck tumors: Thyroid gland. In: Beahrs OH, Henson DE, Hutter RVP, Myers MH (eds) Manual for Staging of Cancer. J.B. Lippincott, Philadelphia, pp. 53-54.
5. Cady B, Rossi R 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
6. Hay I, Grant C, Taylor W, McConahey W 1987 Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102: 1088-1095.
7. Hay I, Bergstralh E, Goellner J, Ebersold J, Grant C 1993 Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057.
8. Pasieka JL, Zedenius J, Auer G, Grimelius L, Höög, A, Lundell G, Wallin G, Bäckdahl M 1992 Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 112:1154-1159.
9. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H 1984 Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715.
10. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J 1992 Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363.
11. Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, Robertson JF, Blamey RW, Ellis IO 1995 Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: Associations with other prognostic factors and survival. Br J Cancer 71:146-149.
12. Brown HM, Komorowski RA, Wilson SD, Demeure MJ, Zhu YR 1999 Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior. Cancer 86:1583-1589.
13. Solcia E KG, Sobin LH (eds) 2000 Histological Typing of Endocrine Tumors, 2nd ed. Berlin, Springer-Verlag.
14. Wallin G, Bäckdahl M, Christensson B, Grimelius L, Auer G 1992 Nuclear protein content and Ki-67 immunoreactivity in nonneoplastic and neoplastic thyroid cells. Anal Quant Cytol Histol 14:296-303.
15. Basolo F, Pollina L, Fontanini G, Fiore L, Pacini F, Baldanzi A 1997 Apoptosis and proliferation in thyroid carcinoma: Correlation with bcl-2 and p53 protein expression. Br J Cancer 75:537-541.
16. Resnick MB, Schacter P, Finkelstein Y, Kellner Y, Cohen O 1998 Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Mod Pathol 11:735-739.
17. Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV 1998 Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol 11:169-174.
18. Yoshida A, Nakamura Y, Imada T, Asaga T, Shimizu A, Harada M 1999 Apoptosis and proliferative activity in thyroid tumors. Surg Today 29:204-208.
19. Katoh R, Bray CE, Suzuki K, Komiyama A, Hemmi A, Kawaoi A, Oyama T, Sugai T, Sasou S 1995 Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum Pathol 26:139-146.
20. Sreelekha TT, Pradeep VM, Vijayalakshmi K, Belthazar A, Chellam VG, Nair MB, Pillai MR 2000 In situ apoptosis in the thyroid. Thyroid 10:117-122.
21. Erickson LA, Jin L, Goellner JR, Lohse C, Pankratz VS, Zukerberg LR, Thompson GB, van Heerden JA, Grant CS, Lloyd RV 2000 Pathologic features, proliferative activity, and cyclin D1 expression in Hürthle cell neoplasms of the thyroid. Mod Pathol 13:186-192.
22. Rickert D, Mittermayer C, Lindenfelser R, Biesterfeld S 2000 MIB-1 immunohistometry of follicular adenoma and follicular carcinoma of the thyroid gland. Anal Quant Cytol Histol 22:229-234.
23. Evan GI, Vousden KH 2001 Proliferation, cell cycle and apoptosis in cancer. Nature 411:342-348.
24. Basolo F, Caligo MA, Pinchera A, Fedeli F, Baldanzi A, Miccoli P, Iacconi P, Fontanini G, Pacini F 2000 Cyclin D1 overexpression in thyroid carcinomas: Relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index. Thyroid 10:741-746.
25. Tallini G, Garcia-Rostan G, Herrero A, Zelterman D, Viale G, Bosari S, Carcangiu ML 1999 Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol 23:678-685.
26. Carcangiu ML, Zampi G, Rosai J 1984 Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma." Am J Surg Pathol 8:655-668.
27. Flynn SD, Forman BH, Stewart AF, Kinder BK 1988 Poorly differentiated ("insular") carcinoma of the thyroid gland: An aggressive subset of differentiated thyroid neoplasms. Surgery 104:963-970.